CSIMarket
 


Kushco Holdings Inc   (KSHB)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Kushco Holdings Inc 's Working Capital Ratio

KSHB's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Current Liabilities decreased faster than Kushco Holdings Inc 's Current Assets, this led to improvement in Kushco Holdings Inc 's Working Capital Ratio to 3.36, Working Capital Ratio remained below Kushco Holdings Inc average.

Within Medical Laboratories industry 30 other companies have achieved higher Working Capital Ratio than Kushco Holdings Inc in third quarter 2021. While Working Capital Ratio total ranking has improved so far during the III Quarter 2021 to 2121, from total ranking in the second quarter 2021 at 2730.

Explain Working Capital Ratio
How much in Current Assets KSHB´s has?
What is the value of KSHB´s Current Liabilities?


KSHB Working Capital Ratio (May 31 2021)
III. Quarter
(Feb 28 2021)
II. Quarter
(Nov 30 2020)
I. Quarter
(Aug 31 2020)
IV. Quarter
(May 31 2020)
III. Quarter
Y / Y Current Liabilities Change 12.65 % 935.46 % 173.03 % 7.8 % -32.4 %
Y / Y Current Assets Change 23.01 % 57.96 % -32.9 % -33.63 % -33.22 %
Working Capital Ratio MRQ 3.36 2.21 1.55 2.28 3.08
KSHB's Total Ranking # 2121 # 2730 # 3059 # 2313 # 1684
Seq. Current Liabilities Change -53.81 % 13.78 % 72.83 % 24.01 % 324.58 %
Seq. Current Assets Change -29.65 % 62.2 % 17.16 % -7.99 % -9.66 %



Working Capital Ratio third quarter 2021 Company Ranking
Within: No.
Medical Laboratories Industry # 31
Healthcare Sector # 817
Overall Market # 2104


Working Capital Ratio Statistics
High Average Low
14.46 3.57 1.55
(Feb 29 2020)   (Nov 30 2020)




Financial Statements
Kushco Holdings Inc 's Current Liabilities $ 23 Millions Visit KSHB's Balance sheet
Kushco Holdings Inc 's Current Assets $ 76 Millions Visit KSHB's Balance sheet
Source of KSHB's Sales Visit KSHB's Sales by Geography


Cumulative Kushco Holdings Inc 's Working Capital Ratio

KSHB's Working Capital Ratio for the trailling 12 Months

KSHB Working Capital Ratio

(May 31 2021)
III. Quarter
(Feb 28 2021)
II. Quarter
(Nov 30 2020)
I. Quarter
(Aug 31 2020)
IV. Quarter
(May 31 2020)
III. Quarter
Y / Y Current Liabilities TTM Growth 12.65 % 935.46 % 173.03 % 7.8 % -32.4 %
Y / Y Current Assets TTM Growth 23.01 % 57.96 % -32.9 % -33.63 % -33.22 %
Working Capital Ratio TTM 2.2 2.14 2.73 4.37 4.95
Total Ranking TTM # 4861 # 4862 # 2111 # 4844 # 4721
Seq. Current Liabilities TTM Growth -53.81 % 13.78 % 72.83 % 24.01 % 324.58 %
Seq. Current Assets TTM Growth -29.65 % 62.2 % 17.16 % -7.99 % -9.66 %


On the trailing twelve months basis KSHB Current Assets grew by 23.01 % in III Quarter 2021 year on year, faster than Current Liabilities, this led to increase in in Kushco Holdings Inc 's Working Capital Ratio to 2.2, Working Capital Ratio remained below KSHB average.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 40 other companies have achieved higher Working Capital Ratio than Kushco Holdings Inc . While Working Capital Ratio overall ranking has improved so far to 4861, from total ranking during the twelve months ending second quarter 2021 at 4862.

Explain Working Capital Ratio
How much in Current Assets KSHB´s has?
What is the value of KSHB´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 41
Healthcare Sector # 1006
Within the Market # 4861


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.66 2.75 1.98
(Feb 28 2017)   (Feb 28 2021)




Companies with similar Working Capital Ratio in the quarter ending May 31 2021, within Medical Laboratories Industry Working Capital RatioMay 31 2021 MRQ Current AssetsMay 31 2021 MRQ Current Liabilities
Caredx Inc   7.84 $ 440.996  Millions$ 56.255  Millions
Opgen inc   7.22 $ 35.070  Millions$ 4.857  Millions
Maxcyte inc   7.10 $ 84.626  Millions$ 11.918  Millions
Viridian Therapeutics Inc   6.86 $ 115.462  Millions$ 16.830  Millions
Vyant Bio Inc   6.48 $ 30.073  Millions$ 4.638  Millions
Burning Rock Biotech Limited  4.89 $ 285.748  Millions$ 58.406  Millions
Genetron Holdings Ltd  4.70 $ 195.709  Millions$ 41.598  Millions
Absci Corp  4.57 $ 112.391  Millions$ 24.581  Millions
Science 37 Holdings Inc   4.08 $ 0.537  Millions$ 0.132  Millions
Incyte Corporation  3.98 $ 2,620.060  Millions$ 657.916  Millions
Natera inc   3.95 $ 739.888  Millions$ 187.341  Millions
Biodesix Inc   3.59 $ 68.450  Millions$ 19.090  Millions
Kushco Holdings Inc   3.36 $ 76.209  Millions$ 22.686  Millions
Psychemedics Corp  3.19 $ 11.736  Millions$ 3.683  Millions
Enzo Biochem Inc  3.12 $ 70.582  Millions$ 22.657  Millions
Hh and l Acquisition Co   2.96 $ 0.991  Millions$ 0.335  Millions
Medpace Holdings Inc   2.89 $ 550.100  Millions$ 190.390  Millions
Ispecimen inc   2.86 $ 16.919  Millions$ 5.926  Millions
Bionexus Gene Lab Corp   2.76 $ 7.099  Millions$ 2.576  Millions
Luna Innovations Inc  2.70 $ 75.897  Millions$ 28.087  Millions
American Shared Hospital Services  2.60 $ 13.449  Millions$ 5.166  Millions
Exact Sciences Corporation  2.53 $ 1,669.211  Millions$ 659.099  Millions
Laboratory Corporation Of America Holdings  2.14 $ 5,717.200  Millions$ 2,667.100  Millions
Charles River Laboratories International inc   1.82 $ 1,267.913  Millions$ 698.281  Millions
Nano x Imaging Ltd  1.80 $ 94.857  Millions$ 52.751  Millions
National Research Corporation  1.69 $ 67.589  Millions$ 39.979  Millions
Hologic Inc  1.65 $ 2,418.200  Millions$ 1,464.600  Millions
Iqvia Holdings Inc   1.57 $ 5,068.000  Millions$ 3,222.000  Millions
Quest Diagnostics Inc  1.53 $ 2,146.000  Millions$ 1,406.000  Millions
Koninklijke Philips Nv  1.38 $ 11,588.640  Millions$ 8,367.520  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com